Bedfont Scientific, based in Maidstone, Kent, donates over 50 Smokerlyzers® to the European Network for Smoking and Tobacco Prevention (ENSP)
Bedfont Scientific, who in 2016 is celebrating 40 years in business, has donated over 50 carbon monoxide breath monitors, famously known as the Smokerlyzer®, to the ENSP.
Bedfont hopes to help them establish carbon monoxide (CO) verification into European Stop Smoking Services (SSS) to motivate people to stop smoking. This decision arrives after success with CO monitoring in Smoking Cessation in the UK, following the publication of the NICE guidelines for Stop Smoking Services in February 2008.
On the 5-6th April 2016, the ENSP, held its hands-on training programme of the Global Bridges grant entitled “European Accreditation Curriculum on Tobacco Treatment”. Funded through a Pfizer Independent Grant for Learning and Change through Global Bridges, this capacity development project aimed to train and certify (with the provision of CME) professionals on treating tobacco dependency in Eastern Europe with a particular focus on clinicians from Romania, Armenia, Georgia, Ukraine and Russia.
Over 190 participants from around the globe participated in an interactive programme, which included keynote presentations from the head of the WHO FCTC secretariat and the head of the Tobacco Unit of the European Commission-DG SANTE among a number of leading researchers in tobacco control and treatment.
The training programme received great enthusiasm from clinicians, health professionals, researchers and KOLs from Eastern Europe, who had the chance to discover and practice carbon monoxide measurements with the Smokerlyzers. Participants really appreciated receiving a CO monitor as part of their training, and looked forward to start using it on their patients.
Dominick Nguyen, Health Policy and Communication Manager at ENSP.
Bedfont is honoured to play a key part in the new movements in Eastern Europe against tobacco dependency. With 30 years on its side, we hope that the Smokerlyzer proves to be as invaluable and effective at helping people quit smoking in Eastern Europe as it has been here in the UK and in our other larger markets.
Jason Smith, General Manager at Bedfont Scientific.